Fundz

Protara Therapeutics Appoints Leonardo Viana Nicacio as Chief Medical Officer

PUBLIC · TARAApr 15, 2025

Position

Chief Medical Officer

Company

Protara Therapeutics

Leonardo Viana Nicacio
leo.nicacio@protaratx.com
New YorkBiotechnologyHealth CareTherapeutics

Description

Protara Therapeutics, Inc has announced the appointment of Dr Leonardo Viana Nicacio as Chief Medical Officer. Dr Nicacio brings nearly 20 years of experience in oncology, drug development, and regulatory affairs.

Quick answer

Protara Therapeutics Appoints Leonardo Viana Nicacio as Chief Medical Officer (April 15, 2025). Protara Therapeutics is based in New York, New York, United States.

Who is the new Chief Medical Officer at Protara Therapeutics?
Protara Therapeutics named Leonardo Viana Nicacio Chief Medical Officer, announced April 15, 2025.
What did Protara Therapeutics announce on April 15, 2025?
Protara Therapeutics, Inc has announced the appointment of Dr Leonardo Viana Nicacio as Chief Medical Officer. Dr Nicacio brings nearly 20 years of experience in oncology, drug development, and regulatory affairs.
What does Protara Therapeutics do?
Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases.
Where is Protara Therapeutics based?
Protara Therapeutics is based in New York, New York, United States.
Which similar companies made leadership changes around the same time?
Parexel (April 15, 2025), Madrigal Pharmaceuticals (April 16, 2025), Inhibikase Therapeutics (April 14, 2025) and Werewolf Therapeutics (April 17, 2025) also announced leadership changes within 45 days of Protara Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Protara Therapeutics, and when

A new leader at Protara Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Protara Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Protara Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Protara Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Protara Therapeutics

Location

New York, New York, United States

About

Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral nutrition who are otherwise unable to meet their choline needs via oral or enteral routes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Protara Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Shane
Senior decision-maker at this company
••••••••@••••••••

See Shane's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Protara Therapeutics's next move

Learn about Strategic plan

Protara Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.